• An uncommon look-alike of multiple sclerosis: Schilder's disease

    A rare MS-like disease that occurs mainly in teenagers and young adults, it is characterised by demyelination of large areas of white matter.

  • Intestinal regeneration by stem cells improves outcomes in apoplexy

    New study results indicate that the intestine could help to minimise the long-term consequences of strokes, showing its role as an important therapeutic target.

  • More than just therapy: psycho-oncology

    A cancer diagnosis completely upsets the lives of the vast majority of those affected. The connection to psycho-oncology can help patients and their relatives.

  • Endometriosis: taking the pain seriously

    Its patients often have a long experience with pain and feel that their suffering is not taken seriously. Actress Amy Schumer has raised awareness on the condition.

  • SARS-CoV-2 damages the DNA and ages cells

    Researchers identified the molecular basis of the aggressive effects of SARS-CoV-2: the virus damages cells' DNA and prevents its repair, causing further effects.

  • Meta-analysis results on child development in LGBTQ+ families

    According to a study published in BMJ Global Health, LGBTQ+ families perform as well or better than 'traditional' families with opposite-sex parents.

  • Impact on speech: About the Foreign Accent Syndrome

    FAS is a rare sign of traumatic brain injury, apoplexy, or multiple sclerosis - but a recent casuistry hinted at an entirely different cause.

  • Alternative contraceptive methods for men

    Recently, there have been more attempts to introduce long-term contraceptive methods for men. One of them is thermal contraception. Dr. Alan Charissou expands on the method.

  • The history of the condom: A journey through time

    Everyone knows them: condoms. But only few know the origins of the humble rubber. We take a look back at the beginnings of male contraceptives.

  • Endoscopic submucosal dissection leaves its mark in Europe

    The ESD technique, which originated in Japan, is being introduced in Europe. This work of medical goldsmiths has precise indications.

  • Fecal hemoglobin concentration: more than just a screening tool

    The fecal occult blood test (FOBT) is used as standard for screening colorectal carcinoma. But even a below benchmark result has clinical relevance.

  • Genetic mutations pave the way to targeted therapy

    In metastasised or relapsed Ewing sarcoma, therapeutic success is often difficult to achieve. According to a study, this could be due to different biomarker variants.

  • Medical History: Marie Curie on the frontline

    Marie Curie is associated with many subjects, and rightly so: With two Nobel prizes won within eight years of each other, she remains one of the most famous scientists of the 20th century.

  • Rare diagnosis: When general symptoms hide a deeper issue

    Nausea, difficulty swallowing, headache: Such general symptoms can also hide a rare disease. Some important differential diagnoses.

  • These signs on the eye may indicate a rare disease

    Rare diseases are often diagnosed late. Collaboration between disciplines can help to refer affected individuals for possible therapy.

  • Chiara Cumella: Patient, medical student, heroine

    Medical student Chiara Cumella suffers from 13 rare diseases and constantly battles not only her illness, but also for her dream of becoming a doctor.

  • European Health Data Space: Treating rare diseases better?

    Can the creation of a common data space ensure better care for people with rare diseases? This and more was discussed at the Tagesspiegel Expert Forum.

  • XLH - Symptoms and treatment

    A gene mutation can trigger XLH - a rare, life-long progressive disease. Skeletal deformities, dental problems, and microsomia are just some of its many symptoms. How to treat it?

  • Case study: Recurrent tonsillitis - What's behind it?

    A young man shows up at emergency with purulent tonsillitis. The examination leads to four suspected diagnoses. Which one would you support?

  • Gene therapy for rare diseases: Where are we now?

    Currently, only a few hundred of the approximately 7,000 rare diseases have an approved treatment option. Gene therapies play a special role, but how far has research progressed?

  • 1 |
  • 2 |
  • 3 |
  • 4 |
  • 5 |
  • 6 |